Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 22 2021


Images mri 2.jpg au lait - colorado_moved.jpg 1.jpg 2.jpg nodules_moved.jpg glioma.jpg
  • summary
    • Neurofibromas are benign peripheral nerve sheath tumors most commonly associated with neurofibromatosis.
    • The condition usually presents in patients with neurofibromatosis with cutaneous lesions, as well as lesions near the brain, spinal cord and parotid glands. 
    • Diagnosis is made with clinical history, physical exam, and MRI with and without contrast.
    • Treatment is observation for asymptomatic lesions. Surgical excision is indicated for symptomatic lesions.  
  • Epidemiology
    • Demographics 
      • sporadic neurofibromas 
        • age 20-40 years
      • Neurofibromatosis (NF1)
        • age < 20 
    • Anatomic location
      • sporadic neurofibromas 
        • peripheral PNS tumors of the extremities
      • Neurofibromatosis (NF1)
        • tendency to be found near spinal cord/brain (CNS) and uncommon locations (parotid glands, tongue)
  • Etiology
    • Cell types
      • fibroblasts (predominant cell)
      • nonmyelinating Schwann cells
        • cell of origin, arises from this cell
      • perineural cells
      • differentiate from Schwannoma, which involves Schwann cell alone
    • Molecular biology
      • arise in nonmyelinating Schwann cells with biallelic inactivation of NF1 tumor-suppressor gene
      • loss of expression of protein neurofibromin
        • neurofibromin negatively regulates RAS-mediated pathway
        • loss of neurofibromin leads to increased RAS activity
        • affects RAS-dependent MAPK activity which is essential for osteoclast function and survival
      • rapid hyperplasia of nonmyelinating Schwann cells into neurofibromas after NF1 inactivation
        • recruits perineural cells, fibroblasts, mast cells, endothelial cells
  • Classification
      • Subtypes of neurofibroma
      • Origin
      • Description
      • Associations
      • Onset
      • Malignancy
      • Dermal
      • Arise from single peripheral nerve
      • Fusiform swelling of nerve
      • 90% sporadic, 10% arise in NF1
      • At puberty
      • Do not become malignant
      • Plexiform
      • Arise from multiple nerve bundles
      • "Bag of worms" (tortuous enlargement of nerves)
      • Pathognomic of NF1
      • Early childhood
      • 10% become malignant (MPNST)
      • Types of Schwann cells
      • Axons
      • Disease process
      • Myelinating
      • Covers large-diameter PNS axons with myelin
      • Nonmyelinating
      • Covers small-diameter PNS axons with cytoplastic processes
      • Responsible for neurofibromatosis
  • Presentation
    • Symptoms
      • asymptomatic
      • stinging, itching, pain, disfiguration
    • Physical exam
      • reduced sensation
      • cutaneous lesions
        • can "button hole" through skin defect using finger pressure
      • signs of neurofibromatosis (2 of 7) (NIH criteria)
        • 2 or more neurofibromas, or 1 plexiform neurofibroma
        • axillary or groin freckling (Crowe's sign)
        • 6 or more coast of California cafe-au-lait spots
          • 5mm diameter in prepubertal
          • >15mm diameter in postpubertal
        • sphenoid wing dysplasia or thinning of long bone cortex (anterolateral tibial bowing)
        • 2 or more Lisch nodules (iris hamartomas)
          • on slit lamp
        • optic glioma
        • 1st degree relative with NF1
      • associated with NF1
        • dystrophic kyphoscoliosis
        • rib penciling
        • intraspinal neurofibromas and dumbbell lesions
        • dural ectasia
        • meningiomas
  • Imaging
    • MRI with and without contrast
      • findings
        • differentiate Schwannoma from neurofibroma
          • Schwannoma are found ECCENTRIC to the nerve fibers
          • Solitary neurofibromas are found CENTRAL to the nerve fibers
      • nerve continuity sign
        • fusiform tumor in continuity with the neurovascular bundle
      • split fat sign
        • fusiform tumor surrounded by a thin margin of fat because the mass within the neurovascular bundle enlarges and displaces the adjacent intramuscular fat
      • target sign
        • lesion of high signal intensity peripherally and low signal centrally (on coronal STIR)
    • PET-CT
  • Histology
    • Characteristics
      • cells
        • hypocellular
        • predominantly fibroblasts
        • mixed Schwann cells, mast cells, lymphocytes
        • elongated, wavy nuclei
      • stroma
        • rich wire-like collagen fiber network
        • may be myxoid
      • distorted structures resembling Pacini or Meissner corpuscles
      • variable S100 staining
  • Differential
    • MPNST (malignant peripheral nerve sheath tumor or neurofibrosarcoma)
      • 5% of patients with NF, 10-25% lifetime risk
      • symptoms include painful, enlarging soft tissue mass
      • usually from plexiform neurofibroma
        • 10% of plexiform neurofibromas transform into MPNST
      • associated with loss of expression of CDKN2A or TP53 genes in non-myelinating Schwann cells (that also have biallelic inactivation of NF1)
      • poor prognosis
        • widespread metastasis
        • high rate of local recurrence
    • Schwannoma
    • Wilms tumor
    • Melanoma
    • Leukemia
    • Rhabdomyosarcoma
    • Pheochromocytoma
  • Treatment
    • Nonoperative
      • observe
        • if asymptomatic
    • Operative
      • surgical excision
        • if symptomatic
        • may require nerve grafting
1 of 0
1 of 4
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options